Vancouver, Canada

Ian Maclachlan

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 10 CIPO patents and 17 EPO patents. Top assignee: Protiva Biotherapeutics, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Maclachlan. Retrieved from https://idiyas.com/inventor/ian-maclachlan-2kre9nn6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Maclachlan: Innovator in Gene Delivery Technologies

Introduction

Ian Maclachlan is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of gene delivery systems. His innovative work has led to the development of methods that enhance the effectiveness of prodrug compounds.

Latest Patents

Ian Maclachlan holds a patent for "Sensitizing cells to compounds using lipid-mediated gene and compound delivery." This invention relates to methods and compositions designed to sensitize a cell to a prodrug compound, thereby improving therapeutic outcomes.

Career Highlights

Throughout his career, Ian has worked with prominent companies in the biotechnology sector. He has been associated with Protiva Biotherapeutics, Inc. and Arbutus Biopharma Corporation, where he has contributed to advancing biotherapeutic technologies.

Collaborations

Ian has collaborated with esteemed colleagues, including Susan S Buchkowsky and Roger W Graham. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Ian Maclachlan's work in gene delivery systems exemplifies the impact of innovative thinking in biotechnology. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…